Tamoxifen Pharmacogenetics of CYP2D6, CYP2C19, and SULTIA1: Long Term Follow-up of the North Central Cancer Treatment Group 89-30-52 Adjuvant Trial.
- Citation:
- Cancer Res vol 69 (2, suppl 1) abstr SABCS-6037
- Meeting Instance:
- SABCS 2009
- Year:
- 2009
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 292
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- M. Goetz V. Suman M. Ames J. Black S. Safgren M. Kuffel R. Avula A. Moyer R. Weinshilboum C. Reynolds E. Perez J. Ingle
- Networks:
- Study
- NCCTG-89-30-52
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: